Question 1

Does Equitable Holdings own SLS stock?

Accepted Answer

No. Equitable Holdings exited its SLS (Sellas Life Sciences Group) position in Q1 2026. Its Q4 2025 13F listed 32,060 shares worth $120,866.

Question 2

How many shares of SLS does Equitable Holdings own?

Accepted Answer

None since Q1 2026, when Equitable Holdings exited the position. Its Q4 2025 13F listed 32,060 shares worth $120,866.

Question 3

What is Equitable Holdings' SLS position worth?

Accepted Answer

Equitable Holdings' SLS position was worth $120,866 in its Q4 2025 13F, before the exit in Q1 2026.

Question 4

Is Equitable Holdings buying or selling SLS?

Accepted Answer

In Q1 2026, Equitable Holdings exited its entire SLS position.

Question 5

When did Equitable Holdings first buy SLS?

Accepted Answer

Equitable Holdings first reported SLS in its Q3 2020 13F and listed it in 22 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q1 Latest	Exited	0	-100.0%	$0	0.0%	$4.23	0
2025-Q4	Increased	32,060	+18.5%	$120,866	0.0%	$3.77	26
2025-Q3	Increased	27,060	+58.6%	$43,567	0.0%	$1.61	29
2025-Q2	Increased	17,060	+41.5%	$37,361	0.0%	$2.19	27
2025-Q1	Unchanged	12,060	0.0%	$13,025	0.0%	$1.08	0
2024-Q4	Unchanged	12,060	0.0%	$12,542	0.0%	$1.04	0
2024-Q3	Decreased	12,060	-94.3%	$15,075	0.0%	$1.25	0